{"id":"https://openalex.org/W2260410163","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.5046","title":"Activity of docetaxel plus trabectedin in recurrent or persistent ovarian and primary peritoneal cancer: A phase II study of the Gynecologic Oncology Group (GOG).","display_name":"Activity of docetaxel plus trabectedin in recurrent or persistent ovarian and primary peritoneal cancer: A phase II study of the Gynecologic Oncology Group (GOG).","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2260410163","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.5046","mag":"2260410163"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.5046","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.5046","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.5046","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014611244","display_name":"Bradley J. Monk","orcid":"https://orcid.org/0000-0001-6985-0159","observed_orcids":["https://orcid.org/0000-0001-6985-0159","https://orcid.org/0000-0002-0680-3184"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. J. Monk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072447565","display_name":"Michael W. Sill","orcid":"https://orcid.org/0000-0001-7263-2179","observed_orcids":["https://orcid.org/0000-0001-7263-2179"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Sill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053990407","display_name":"Joan L. Walker","orcid":"https://orcid.org/0000-0002-5034-4309","observed_orcids":["https://orcid.org/0000-0002-5034-4309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. L. Walker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109906302","display_name":"P. Hanjani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Hanjani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070555068","display_name":"Robert P. Edwards","orcid":"https://orcid.org/0000-0003-0370-1390","observed_orcids":["https://orcid.org/0000-0003-0370-1390"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. P. Edwards","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043175553","display_name":"Jacob Rotmensch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Rotmensch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008929073","display_name":"Koen De Geest","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. De Geest","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056632427","display_name":"Albert J. Bonebrake","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. J. Bonebrake","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"5046","last_page":"5046"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9950000047683716},{"id":"https://openalex.org/keywords/trabectedin","display_name":"trabectedin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.9810000061988831},{"id":"https://openalex.org/keywords/primary-peritoneal-cancer","display_name":"primary peritoneal cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7570000290870667},{"id":"https://openalex.org/keywords/filgrastim","display_name":"filgrastim","score":0.6499999761581421},{"id":"https://openalex.org/keywords/pegfilgrastim","display_name":"pegfilgrastim","score":0.9290000200271606},{"id":"https://openalex.org/keywords/sargramostim","display_name":"sargramostim","score":0.968999981880188},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8190000057220459},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7879999876022339},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8899999856948853},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.5889999866485596},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.460999995470047},{"id":"https://openalex.org/keywords/two-stage-design","display_name":"two-stage design","score":0.6919999718666077},{"id":"https://openalex.org/keywords/historical-control-comparison","display_name":"historical control comparison","score":0.6819999814033508},{"id":"https://openalex.org/keywords/toxicity-profile","display_name":"toxicity profile","score":0.31700000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8683074712753296},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.7588919401168823},{"id":"https://openalex.org/C2780752271","wikidata":"https://www.wikidata.org/wiki/Q2637746","display_name":"Trabectedin","level":4,"score":0.755021333694458},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.7549304962158203},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.6652036905288696},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6338094472885132},{"id":"https://openalex.org/C2780435969","wikidata":"https://www.wikidata.org/wiki/Q5625186","display_name":"Gynecologic oncology","level":2,"score":0.5719412565231323},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5081517696380615},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4303935170173645},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4178132712841034},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34555327892303467},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3422728478908539},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3001707196235657},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.2562481462955475},{"id":"https://openalex.org/C136948725","wikidata":"https://www.wikidata.org/wiki/Q1458306","display_name":"Soft tissue","level":2,"score":0.0},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.5046","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.5046","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.5046","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2105928179","https://openalex.org/W3150366960","https://openalex.org/W1989653888","https://openalex.org/W2041142804","https://openalex.org/W3080642302","https://openalex.org/W2267390660","https://openalex.org/W1975444361","https://openalex.org/W2736512149","https://openalex.org/W2757197905","https://openalex.org/W2893245927"],"abstract_inverted_index":{"5046":[0],"Background:":[1],"To":[2],"estimate":[3],"the":[4,118,154,158,169,178,193],"activity":[5,176],"of":[6,59,86,95,109,160,171,189,225,234,276,303,333],"docetaxel":[7],"60":[8],"mg/m2":[9,18],"IV":[10],"over":[11,19],"1":[12,71,78],"hr":[13],"followed":[14],"by":[15,162],"trabectedin":[16],"1.1":[17],"3":[20,28,66,219],"hrs":[21],"with":[22,43,104,164,174,203,278,323],"filgrastim,":[23],"pegfilgrastim,":[24],"or":[25,35,342,346],"sargramostim":[26],"every":[27],"weeks":[29],"(one":[30],"cycle)":[31],"until":[32],"disease":[33],"progression":[34],"adverse":[36],"effects":[37],"prohibit":[38],"further":[39],"therapy.":[40],"Methods:":[41],"Patients":[42,75],"recurrent":[44,324],"and":[45,51,137,207,258,264,312,326],"measurable":[46],"disease,":[47],"acceptable":[48],"organ":[49],"function,":[50],"PS":[52],"\u2264":[53],"2":[54,216],"were":[55,201,296],"eligible.":[56],"The":[57,146,186,222,232,243,254,268],"number":[58,188,224,233],"prior":[60,79],"cytotoxic":[61,80],"regimens":[62,173],"was":[63,102,149,196,227,237,248,261,272],"limited":[64],"to":[65,151,184,191],"(including":[67],"no":[68,297],"more":[69,314],"than":[70,316],"non-platinum,":[72],"non-taxane":[73],"regimen).":[74],"receiving":[76],"only":[77],"regimen":[81,83,156,194],"(platinum-based":[82],"for":[84,143,246],"management":[85],"primary":[87],"disease)":[88],"must":[89],"have":[90],"had":[91],"a":[92,105,123,140],"platinum-free":[93],"interval":[94],"<":[96],"12":[97],"mo.":[98,274],"A":[99],"two-stage":[100],"design":[101],"utilized":[103],"target":[106],"sample":[107],"size":[108],"35":[110],"subjects":[111,133,277],"per":[112],"stage.":[113],"Another":[114],"GOG":[115],"study":[116,148,336],"within":[117],"same":[119],"protocol":[120],"queue":[121],"involving":[122],"single":[124,317],"agent":[125,318],"taxane":[126,319],"yielded":[127],"8":[128],"responses":[129,190],"(16%)":[130],"among":[131],"49":[132],"(90%":[134,250],"CI":[135,241,252],"8.6-28.5%)":[136],"served":[138],"as":[139,177,181],"historical":[141,179],"control":[142,180],"direct":[144],"comparison.":[145],"current":[147,155],"designed":[150],"determine":[152],"if":[153],"increased":[157],"probability":[159,170],"response":[161,270],"20%":[163],"90%":[165,240],"power":[166],"while":[167],"limiting":[168],"declaring":[172],"similar":[175],"being":[182,205],"interesting":[183,195],"10%.":[185],"minimum":[187],"declare":[192],"21.":[197],"Results:":[198],"71":[199],"patients":[200,235],"enrolled":[202],"70":[204],"eligible":[206],"evaluable":[208],"at":[209],"this":[210],"time":[211],"(prior":[212],"regimens:1":[213],"=":[214,217,220],"29%,":[215],"51%,":[218],"20%).":[221],"median":[223,255,269],"cycles":[226],"6":[228],"(396":[229],"total":[230],"cycles).":[231],"responding":[236,247],"21":[238],"(30%;":[239],"21-40%).":[242],"odds":[244],"ratio":[245],"2.2":[249],"1-sided":[251],"1.09\u2013Infinity).":[253],"progression-free":[256],"survival":[257,260],"overall":[259],"4.4":[262],"mo":[263],"12.5":[265],"mo,":[266],"respectively.":[267],"duration":[271],"8.4":[273],"Numbers":[275],"grade":[279],"3/4":[280],"toxicity":[281],"included:":[282],"neutropenia":[283],"6/14;":[284],"constitutional":[285],"8/0;":[286],"GI":[287],"(excluding":[288],"nausea/vomiting)":[289],"10/0;":[290],"metabolic":[291],"9/1;":[292],"pain":[293],"6/0.":[294],"There":[295],"treatment":[298],"related":[299],"deaths":[300],"nor":[301],"cases":[302],"liver":[304],"failure.":[305],"Conclusions:":[306],"This":[307],"combination":[308],"is":[309,337],"well":[310],"tolerated":[311],"appears":[313],"active":[315],"therapy":[320],"in":[321],"those":[322],"ovarian":[325],"peritoneal":[327],"cancer":[328],"after":[329],"failing":[330],"multiple":[331],"lines":[332],"chemotherapy.":[334],"Further":[335],"warranted.":[338],"Author":[339],"Disclosure":[340],"Employment":[341],"Leadership":[343],"Position":[344],"Consultant":[345],"Advisory":[347],"Role":[348],"Stock":[349],"Ownership":[350],"Honoraria":[351],"Research":[352],"Funding":[353],"Expert":[354],"Testimony":[355],"Other":[356],"Remuneration":[357],"Johnson":[358,360,361,363,364,366,367,369],"&":[359,362,365,368]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}